Effect of brachytherapy on NF-κB and VEGF in gastric carcinoma xenografts

Zhang,Wan-Fu; Jin,Wen-Di; Li,Bo; Wang,Ming-Chun; Li,Xiao-Gang; Mao,Wen-Yuan; Luo,Kai-Yuan

doi:10.3892/or.2014.3255

Effect of brachytherapy on NF-κB and VEGF in gastric carcinoma xenografts

Authors:
- Wan-Fu Zhang
- Wen-Di Jin
- Bo Li
- Ming-Chun Wang
- Xiao-Gang Li
- Wen-Yuan Mao
- Kai-Yuan Luo
View Affiliations

Affiliations: Department of General Surgery, The Second People's Hospital of Yunnan Province, Kunming, Yunnan 650500, P.R. China
Published online on: June 12, 2014 https://doi.org/10.3892/or.2014.3255
Pages: 635-640

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Iodine-125 (125I) seed irradiation can be used as an important supplementary treatment for unresectable advanced gastric cancer. However, the radiobiological mechanism underlying brachytherapy remains unclear. Therefore, we investigated the influence of continuous and low-energy 125I irradiation on the cell cycle distribution, apoptosis, expression of NF-κB and VEGF and tumor growth in a human gastric cancer xenograft model. To create an animal model of gastric cancer, SGC-7901 cells were surgically implanted into mice. The 60 mice bearing SGC-7901 gastric cancer xenografts were randomly separated into 2 groups. Sham seeds (0 mCi) were implanted into the control group (n=30); 125I seeds (0.6 mCi) were implanted into the treatment group (n=30). At 28 days after irradiation, apoptosis was detected by flow cytometry. fluorescence micrograph detected intense VEGF and NF-κB immunofluorescence in the tumor samples, and changes in NF-κB and VEGF mRNA and protein expression were assessed by real-time PCR and western blot analysis, respectively. The tumor volume and weight were measured 0-28 days after 125I seed implantation. 125I seed irradiation induced significant apoptosis and G2/M phase arrest. Reduction in the intensities of VEGF and NF-κB immunofluorescence in tumor vessels was observed after treatment. NF-κB and VEGF mRNA and protein expression levels were substantially lower in the implantation treatment group than in the control group. Consequently, 125I seed implantation inhibited cancer growth and reduced cancer volume. The present study revealed that 125I seed irradiation significantly induced apoptosis and cell cycle arrest in the human gastric cancer xenografts. 125I-induced changes in NF-κB and VEGF expression are suggested as potential mechanisms underlying effective brachytherapy.

View Figures

View References

1	Power DG, Kelsen DP and Shah MA: Advanced gastric cancer-slow but steady progress. Cancer Treat Rev. 36:384–392. 2010. View Article : Google Scholar : PubMed/NCBI
2	Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, et al: Management of gastric cancer in Asia: resource-stratified guidelines. Lancet Oncol. 14:e535–e547. 2013.PubMed/NCBI
3	Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
4	Joensuu H, Vehtari A, Riihimäki J, Nishida T, Steigen SE, Brabec P, Plank L, et al: Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts. Lancet Oncol. 13:265–274. 2012. View Article : Google Scholar : PubMed/NCBI
5	Marrelli D, De Stefano A, de Manzoni G, Morgagni P, Di Leo A and Roviello F: Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg. 241:247–255. 2005. View Article : Google Scholar : PubMed/NCBI
6	Merrick GS, Wallner KE and Butler WM: Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland. J Urol. 169:1643–1652. 2003. View Article : Google Scholar : PubMed/NCBI
7	Roeloffzen EM, Monninkhof EM, Battermann JJ, et al: Acute urinary retention after I-125 prostate brachytherapy in relation to dose in different regions of the prostate. Int J Radiat Oncol Biol Phys. 80:76–84. 2011. View Article : Google Scholar : PubMed/NCBI
8	Lee W, Daly BD, DiPetrillo TA, et al: Limited resection for non-small cell lung cancer: observed local control with implantation of I-125 brachytherapy seeds. Ann Thorac Surg. 75:237–243. 2003. View Article : Google Scholar : PubMed/NCBI
9	Zhuang HQ, Wang JJ, Liao AY, Wang JD and Zhao Y: The biological effect of ¹²⁵I seed continuous low dose rate irradiation in CL187 cells. J Exp Clin Cancer Res. 28:122009.
10	Ma JX, Jin ZD, Si PR, Liu Y, Lu Z, Wu HY, Pan X, et al: Continuous and low-energy ¹²⁵I seed irradiation changes DNA methyltransferases expression patterns and inhibits pancreatic cancer tumor growth. J Exp Clin Cancer Res. 30:352011.PubMed/NCBI
11	Wang JJ, Yuan HS, Li JN, Jiang WJ, Jiang YL and Tian SQ: Interstitial permanent implantation of ¹²⁵I seeds as salvage therapy for re-recurrent rectal carcinoma. Int J Colorectal Dis. 24:391–399. 2009.PubMed/NCBI
12	Shi L, Wu C, Wu J, Zhou W, Ji M, Zhang H, et al: Computed tomography-guided permanent brachytherapy for localregional recurrent gastric cancer. Radiat Oncol. 7:1142012. View Article : Google Scholar : PubMed/NCBI
13	Wang J, Sui A, Jia Y, Xu B, Wei L, Chen J and Shen W: Treatment of unresectable advanced gastric cancer using iodine-125 brachytherapy. Chin J Clin Oncol. 3:212–215. 2006. View Article : Google Scholar
14	Takabayashi K, Kashiwagi K, Kawata T, Sato T, Matsuoka K, Hisamatsu T, Takaishi H, et al: Continuous low-dose irradiation by I-125 seeds induces apoptosis of gastric cancer cells regardless of histological origin. Cancer Biol Ther. 5:81–88. 2014. View Article : Google Scholar : PubMed/NCBI
15	Ma ZH, Yang Y, Zou L and Luo KY: 125I seed irradiation induces up-regulation of the genes associated with apoptosis and cell cycle arrest and inhibits growth of gastric cancer xenografts. J Exp Clin Cancer Res. 31:612012. View Article : Google Scholar : PubMed/NCBI
16	Li ZM, Pu YW and Zhu BS: Blockade of NF-κB nuclear translocation results in the inhibition of the invasiveness of human gastric cancer cells. Oncol Lett. 6:432–436. 2013.
17	Cao W, Fan R, Yang W and Wu Y: VEGF-C expression is associated with the poor survival in gastric cancer tissue. Tumour Biol. Dec 5–2013.(Epub ahead of print).
18	Yang Z, Jin C, Chen T, Sun H, Yang D, Huang Y, Zhang J, et al: Changes in cell cycle, apoptosis and necrosis following the establishment of a ¹²⁵I brachytherapy model in the spinal cord in Banna mini-pigs. Oncol Lett. 3:315–320. 2012.PubMed/NCBI
19	Santos-Silva F: Oncogenic signaling in gastric carcinoma. Gastric Carcinoma - Molecular Aspects and Current Advances. Lotfy M: InTech; Rijeka, Croatia: 2011, View Article : Google Scholar : Available from: http://www.intechopen.com/books/gastric-carcinomamolecularaspectsandcurrentdvances/oncogenicsignalingingastriccarcinoma.
20	Yan Y, Greer PM, Cao PT, Kolb RH and Cowan KH: RAC1 GTPase plays an important role in γ-irradiation induced G₂/M checkpoint activation. Breast Cancer Res. 14:R602012.
21	Zhang J, Peng B and Chen X: Expressions of nuclear factor κB, inducible nitric oxide synthase and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clin Cancer Res. 11:7334–7343. 2005.
22	Zhang J and Peng B: In vitro angiogenesis and expression of nuclear factor κB and VEGF in high and low metastasis cell lines of salivary gland adenoid cystic carcinoma. BMC Cancer. 7:952007.
23	Fujioka S, Sclabas GM, Schmidt C, Frederick WA, Dong QG, Abbruzzese JL, et al: Function of nuclear factor κB in pancreatic cancer metastasis. Clin Cancer Res. 9:346–354. 2003.
24	Du ZX, Zhang HY, Gao DX, Wang HQ, Li YJ and Liu GL: Significance of VEGF and NF-κB expression in thyroid carcinoma. Chin J Clin Oncol. 3:166–171. 2006.
25	Sasaki N, Morisaki T, Hashizume K, Yao T, Tsuneyoshi M, Noshiro H, et al: Nuclear factor κB p65 (RelA) transcription factor is constitutively activated in human gastric carcinoma tissue. Clin Cancer Res. 7:4136–4142. 2001.
26	Tsuboi K, Matsuo Y, Shamoto T, Shibata T, Koide S, Morimoto M, et al: Zerumbone inhibits tumor angiogenesis via NF-κB in gastric cancer. Oncol Rep. 31:57–64. 2014.PubMed/NCBI
27	Kang MJ, Ryu BK, Lee MG, Han J, Lee JH, Ha TK, Byun DS, et al: NF-κB activates transcription of the RNA-binding factor HuR, via PI3K-AKT signaling, to promote gastric tumorigenesis. Gastroenterology. 135:e2031–e2033. 2008.
28	Liu X, Wang X, Zhang J, Lam EK, Shin VY, Cheng AS, et al: Warburg effect revisited: an epigenetic link between glycolysis and gastric carcinogenesis. Oncogene. 29:442–450. 2010. View Article : Google Scholar : PubMed/NCBI
29	Raica M, Mogoantă L, Cîmpean AM, Alexa A, Ioanovici S, Mărgăritescu C, et al: Immunohistochemical expression of vascular endothelial growth factor (VEGF) in intestinal type gastric carcinoma. Rom J Morphol Embryol. 49:37–42. 2008.PubMed/NCBI
30	Kitadai Y: Angiogenesis and lymphangiogenesis of gastric cancer. J Oncol. 2010:4687252010. View Article : Google Scholar